Lipid Nanoparticles-Based mRNA Delivery System offers a comprehensive exploration of lipid nanoparticles (LNPs), the most promising delivery vehicles for mRNA. The book consolidates current knowledge, identifies research gaps, and provides insights into the latest developments in LNP technologies, making it an essential resource for researchers, pharmaceutical developers, and clinicians at the forefront of mRNA therapeutics. Exploring the intricacies of LNP formulation, the book covers a wide range of topics, including the fundamental principles of lipid nanoparticles, design strategies for effective mRNA encapsulation, and the unique challenges associated with various routes of administration—such as intravenous, oral, transdermal, and intranasal delivery.
The book also examines the therapeutic applications of lipid-based systems, particularly in vaccines and cancer immunotherapy, while addressing critical challenges like immunogenicity and regulatory considerations. Final sections provide a forward-looking perspective on future trends and innovations in lipid-based mRNA delivery systems, ensuring that readers are well-equipped to navigate this rapidly evolving field.
1. Chapter 1. Introduction to RNAi therapeutics - p. 3 2. Chapter 2. Lipid-based mRNA delivery systems - p. 21 3. Chapter 3. LNP-mRNA therapeutics: Mechanism of action - p. 39 4. Part II. Design and formulation of lipid nanoparticles for mRNA delivery - p. P2 5. Chapter 4. Lipid nanoparticles formulation strategies - p. 63 6. Part III. Administration routes for lipid-based mRNA delivery - p. P3 7. Chapter 5. Intravenous administration of LNP-mRNA therapeutics - p. 93 8. Chapter 6. Oral administration of mRNA-LNP therapeutics - p. 113 9. Chapter 7. Transdermal delivery of LNP-mRNA therapeutics delivery - p. 129 10. Chapter 8. Intranasal administration of LNP-mRNA therapeutics - p. 147 11. Chapter 9. Intramuscular administration of LNP-mRNA therapeutics - p. 173 12. Part IV. Applications of lipid-based mRNA delivery systems - p. P4 13. Chapter 10. LNP-mRNA vaccines: Revolutionizing preventive medicine - p. 191 14. Chapter 11. Lipid nanoparticles–mRNA platforms: Advancing cancer immunotherapy - p. 217 15. Part V. Challenges, solutions, and future directions - p. P5 16. Chapter 12. LNP-mRNA immunogenicity and toxicity - p. 241 17. Chapter 13. Regulatory considerations for mRNA-LNP-based therapeutics - p. 271 18. Chapter 14. Future trends in LNP-mRNA therapeutics - p. 295 19. Index - p. 311
Lipid Nanoparticles-Based mRNA Delivery System offers a comprehensive exploration of lipid nanoparticles (LNPs), the most promising delivery vehicles for mRNA. The book consolidates current knowledge, identifies research gaps, and provides insights into the latest developments in LNP technologies, making it an essential resource for researchers, pharmaceutical developers, and clinicians at the forefront of mRNA therapeutics. Exploring the intricacies of LNP formulation, the book covers a wide range of topics, including the fundamental principles of lipid nanoparticles, design strategies for effective mRNA encapsulation, and the unique challenges associated with various routes of administration—such as intravenous, oral, transdermal, and intranasal delivery.
The book also examines the therapeutic applications of lipid-based systems, particularly in vaccines and cancer immunotherapy, while addressing critical challenges like immunogenicity and regulatory considerations. Final sections provide a forward-looking perspective on future trends and innovations in lipid-based mRNA delivery systems, ensuring that readers are well-equipped to navigate this rapidly evolving field.
1. Chapter 1. Introduction to RNAi therapeutics - p. 3 2. Chapter 2. Lipid-based mRNA delivery systems - p. 21 3. Chapter 3. LNP-mRNA therapeutics: Mechanism of action - p. 39 4. Part II. Design and formulation of lipid nanoparticles for mRNA delivery - p. P2 5. Chapter 4. Lipid nanoparticles formulation strategies - p. 63 6. Part III. Administration routes for lipid-based mRNA delivery - p. P3 7. Chapter 5. Intravenous administration of LNP-mRNA therapeutics - p. 93 8. Chapter 6. Oral administration of mRNA-LNP therapeutics - p. 113 9. Chapter 7. Transdermal delivery of LNP-mRNA therapeutics delivery - p. 129 10. Chapter 8. Intranasal administration of LNP-mRNA therapeutics - p. 147 11. Chapter 9. Intramuscular administration of LNP-mRNA therapeutics - p. 173 12. Part IV. Applications of lipid-based mRNA delivery systems - p. P4 13. Chapter 10. LNP-mRNA vaccines: Revolutionizing preventive medicine - p. 191 14. Chapter 11. Lipid nanoparticles–mRNA platforms: Advancing cancer immunotherapy - p. 217 15. Part V. Challenges, solutions, and future directions - p. P5 16. Chapter 12. LNP-mRNA immunogenicity and toxicity - p. 241 17. Chapter 13. Regulatory considerations for mRNA-LNP-based therapeutics - p. 271 18. Chapter 14. Future trends in LNP-mRNA therapeutics - p. 295 19. Index - p. 311
